Heavy Metal Index

Children's Cadmium-Containing Metal Jewelry — Staff Report

Source access

Publication
U.S. Consumer Product Safety Commission, Directorate for Health Sciences (Staff Report, October 2010)
Year
2010
Authors
Hatlelid, Kristina M.; Williams, Dominique J.; Church, Colin
Source type
gov guidance
License
public reference only

CPSC (2010) — Children’s Cadmium-Containing Metal Jewelry (Staff Report)

This 109-page U.S. Consumer Product Safety Commission staff document was transmitted on October 19, 2010 from Colin Church (Voluntary Standards Coordinator) to Brent Cleaveland (Chairman, ASTM F-15.24 Subcommittee on Children’s Jewelry), to support development of an ASTM voluntary safety standard for cadmium in children’s metal jewelry. The body of the document comprises three CPSC staff memoranda dated October 14, 2010: (i) the Staff Report on Children’s Cadmium-Containing Metal Jewelry authored by Kristina M. Hatlelid, Ph.D., M.P.H. (Toxicologist, Directorate for Health Sciences); (ii) TAB A: Staff Responses to Peer Review Comments on the draft staff report; and (iii) TAB B: Toxicity Review of Cadmium authored by Dominique J. Williams and Kristina M. Hatlelid. All three memoranda carry the standard CPSC staff caveat that the contents “are those of the CPSC staff and have not been reviewed or approved by, and may not necessarily reflect the views of, the Commission.” The Staff Report’s role in the CPSC Federal Hazardous Substances Act (FHSA) regulatory regime is to derive an acceptable daily intake level (ADI) for cadmium, translate that ADI into per-item extraction-test thresholds that distinguish products that may meet FHSA hazardous-substance criteria from those that do not, and to set out the staff’s assessment approach for cadmium-containing metal jewelry intended for children. No primary jewelry-content measurements are reported in this document; the cover letter references separate jewelry test-result enclosures (“Tabs A and B” in the October 19, 2010 transmittal letter) that are not contained in this 109-page PDF file.

Key numbers

Cover-letter framing (Colin Church to Brent Cleaveland, October 19, 2010)

  • Originating CPSC staff position (p. 1 of cover letter): “CPSC staff concluded that a test method for chemicals that migrate from small items that can be swallowed, especially metal items, should be based on measuring solubility in an acidic solution over 24 hours. This conclusion is based on the results of testing hundreds of jewelry and metal alloy samples, as well as on information about the length of time an ingested foreign object could be present in the digestive tract of a child.”
  • CPSC staff position on existing two-hour toy-safety extraction methods (p. 1 of cover letter): “CPSC staff believes that the test methods in the toy safety standards ASTM F-963 and EN-71-3, which specify measuring solubility of the chemicals after two hours, are inadequate for evaluating potential chemical exposures from products such as metal jewelry.”

Staff Report (Hatlelid, October 14, 2010) — derived ADIs and test thresholds

  • Acceptable Daily Intake (ADI), chronic oral cadmium exposure: 0.1 µg/kg/day (p. 5 of Staff Report). Derived as the cadmium intake level of 0.33 µg/kg/day (the ATSDR 2008 PK-modelled intake corresponding to the Suwazono et al. 2006 urinary cadmium BMDL of 0.5 µg cadmium per gram creatinine) divided by an uncertainty factor of 3 to account for sensitive subpopulations (reduced from the default factor of 10 because of the strength of the supporting human-population evidence). “This is the level of chronic exposure that should not be exceeded to avoid adverse health effects.”
  • Acceptable Daily Intake (ADI), acute oral cadmium exposure: 11 µg/kg/day (p. 7 of Staff Report). Derived as the NOAEL of 1.1 mg/kg/day from Borzelleca et al. (1989) — a 10-day cadmium-chloride drinking-water study in Sprague-Dawley rats — divided by an uncertainty factor of 100 (10× for use of animal data instead of human data; 10× for sensitive individuals in the human population).
  • Body-weight assumption for young children (ages 2–6 years): 18.2 kg (≈ 40 lb), from Ogden et al. 2004 (p. 8 of Staff Report).
  • Maximum allowable chronic exposure for a young child: 1.8 µg/day (p. 8 of Staff Report). Computed as 0.1 µg/kg/day × 18.2 kg = 1.82 µg/day, reported as “about 1.8 µg/day.”
  • Maximum allowable acute exposure for a young child: about 200 µg/day (p. 8 of Staff Report). Computed as 11 µg/kg/day × 18.2 kg = 200.2 µg/day.
  • Mouthing-time assumption (ages 24–36 months, all objects excluding pacifiers): 37 minutes/day average daily mouthing time, from CPSC (2001) mouthing observation study (p. 9 of Staff Report).
  • Saline extraction threshold for mouthable cadmium-containing jewelry: a 6-hour saline-extraction laboratory result that exceeds 18 µg total cadmium indicates the product may meet FHSA hazardous-substance criteria based on chronic toxicity (p. 9 of Staff Report). Derivation: (1.8 µg/day) / (37 min/day) × (6 hours × 60 min/hour) = 18 µg total cadmium extracted in the 6-hour saline test (Eq. 1, p. 9 of Staff Report).
  • Acid extraction threshold for swallowable cadmium-containing jewelry: a 24-hour acid-extraction laboratory result that exceeds 200 µg total cadmium indicates the product may meet FHSA hazardous-substance criteria based on acute toxicity (p. 10 of Staff Report). Derivation: the acute ADI of 200 µg/day is treated as the total exposure that can occur within the short time an ingested item remains in the GI tract.
  • Laboratory protocol: CPSC’s standard laboratory procedure for evaluating possible mouthing exposure is 6-hour saline extraction; for evaluating possible swallowing exposure of metal jewelry items the protocol is 24-hour dilute hydrochloric acid extraction (p. 9 of Staff Report). The 24-hour acid extraction duration is based on data showing that ingested items sometimes remain in the stomach for several days; CPSC staff data indicate that 24 hours is generally sufficient to identify products that could leach large amounts of chemicals.
  • Critical exposure level used to derive the chronic ADI: cadmium intake of 0.33 µg/kg/day (p. 4 of Staff Report), from ATSDR (2008) PK modelling of European-population cadmium intake corresponding to a urinary cadmium concentration of 0.5 µg cadmium per gram creatinine — the lower bound of the BMDL (5 % excess risk of pHC proteinuria) reported by Suwazono et al. (2006) in 820 Swedish women.

Existing exposure limits surveyed by CPSC staff (Staff Report, p. 3)

  • WHO/JECFA Provisional Tolerable Monthly Intake (PTMI) for cadmium: 25 µg/kg body weight/month (JECFA 2010), equivalent to about 0.8 µg/kg/day.
  • U.S. EPA oral reference dose (RfD) for cadmium: 1 µg/kg/day for food intake; 0.5 µg/kg/day for cadmium in drinking water (EPA 1994 IRIS).
  • U.S. EPA cadmium-in-drinking-water limits: 0.04 mg/L for exposures up to 10 days; 0.005 mg/L for lifetime exposures (EPA 2003).
  • U.S. FDA bottled-water cadmium limit: 0.005 mg/L (FDA 2009).
  • OSHA occupational inhalation limit (8-hour TWA): 5 µg/m³ cadmium in air (OSHA 2009).
  • ATSDR chronic-duration oral Minimal Risk Level (MRL): 0.1 µg/kg/day (ATSDR 2008 draft toxicological profile), based on kidney effects in humans.
  • ATSDR intermediate-duration oral MRL: 0.5 µg/kg/day (ATSDR 2008 draft toxicological profile), based on effects on bone in experimental animals; no acute-duration MRL has been derived due to inadequacies in the acute oral exposure database.
  • European Standard EN 71-3 (1994) safety-of-toys cadmium migration limit: 0.6 µg/day cadmium from toys for young children, based on background cadmium intake levels and a policy decision to limit cadmium exposure from toys to 5 percent of the assumed background exposure.
  • European Council Directive 2009/48/EC (effective July 20, 2013) cadmium toy-safety limit: about 0.2 µg/day cadmium from toys (Staff Report notes these toy-safety daily limits are not body-weight-adjusted but are based on the weight of a young child, 7.5 kg ≈ 16.5 lb, for the revised standard).

Acute-toxicity literature reviewed (Staff Report, p. 5–6)

  • Documented severe-poisoning case (Nordberg et al. 1973): boys ages 13–15 years drank a beverage from a soda machine containing 16 mg/L cadmium. Onset of symptoms (headache, nausea, vomiting, abdominal pain, diarrhoea) within 15 minutes of consumption; symptoms resolved within 7 hours. Reported consumption: 0.5–2.5 glasses (average about one glass; ≈ 0.15 L), giving an estimated cadmium dose of about 2.4 mg total. CPSC staff considered the documentation inadequate for quantitative derivation of an exposure limit.
  • Acute oral LD50 for cadmium in rats and mice: approximately 100–300 mg/kg (Baer and Benson 1987; Kostial et al. 1978; Kostial et al. 1979).
  • Lowest dose found to cause death in rats: 15.3 mg/kg cadmium chloride administered as a single gavage dose in Sprague-Dawley rats (2 of 20 animals; Borzelleca et al. 1989).
  • Other acute oral effects in rats (Baranski 1985; Borzelleca et al. 1989; Machemer and Lorke 1981): reduced body weight or reduced body weight gain at cadmium doses greater than about 2 mg/kg/day; haemorrhages, ulcers, and reddening of the stomach and intestinal tract at 61 mg/kg/day; testicular atrophy at 66 mg/kg/day; necrotic changes in the kidney at 15.3 mg/kg/day and in the liver at 138 mg/kg/day.
  • Selected key acute study (Borzelleca et al. 1989): 10-day cadmium-chloride drinking-water exposure in male and female rats (strain not specified for the drinking-water arm in the Staff Report; the companion single-dose gavage arm in Borzelleca et al. 1989 used Sprague-Dawley rats, per TAB B p. 23); doses 1.1, 7.8, and 11.1 mg/kg/day in males and 1.1, 8.1, and 13.8 mg/kg/day in females. Dose-dependent decrease in body weight gain in males; reduced body weight in the highest-dose group in males; dose-related reduced body weight gain in females (no statistical analysis presented). A companion gavage study by the same authors at comparable doses also produced reduced body weight and reduced body weight gain, supporting that the effects are not attributable to drinking-water taste aversion. NOAEL = 1.1 mg/kg/day (the lowest dose tested in the drinking-water study), the basis for the 11 µg/kg/day acute ADI after a 100-fold uncertainty factor.

Long-term and dose-response cadmium toxicity (TAB B Toxicity Review, p. 21–30)

  • U.S. NHANES (2003–2004, CDC 2009) population biomonitoring (≥ 20 years of age): geometric mean blood cadmium 0.378 µg/L; geometric mean urine cadmium 0.260 µg/L. Females: blood cadmium 0.326 µg/L, urine cadmium 0.216 µg/L. Males: blood cadmium 0.283 µg/L, urine cadmium 0.206 µg/L (TAB B, p. 21).
  • Estimated cadmium half-life in human tissues (Kjellström and Nordberg 1978, 1985 toxicokinetic model): 6–38 years in kidney; 4–19 years in liver (TAB B, p. 23).
  • Estimated daily excretion fractions of body cadmium burden (Kjellström and Nordberg model): 0.007 percent/day in feces; 0.009 percent/day in urine (TAB B, p. 23). (TAB B contains an internal contradiction on the urine-vs-feces attribution: p. 22 of the Toxicokinetics section reports the fractions as urine = 0.007 % and feces = 0.009 %, while p. 23 of the Elimination section reports the same fractions as feces = 0.007 % and urine = 0.009 %. The wiki value above adopts the p. 23 Elimination-section attribution; see Verification notes for the source-citation evidence on both pages.) Oral absorption of ingested cadmium: approximately 1–10 percent (ATSDR 2008; TAB B, p. 22). Dermal absorption: less than 1 percent of administered dose (ATSDR 2008; TAB B, p. 22).
  • Age-related kidney/liver cadmium accumulation (Kjellström 1979): geometric mean tissue concentrations increase from less than 1 µg/g in early childhood to a peak of 40–50 µg/g in the kidney and 3–4 µg/g in the liver at around 50–60 years of age, then decrease over time after age 60 (TAB B, p. 22).
  • Järup et al. (2000) — Swedish kidney epidemiology near a Ni-Cd battery plant: 1,021 individuals (n=799 living near plant; n=222 battery workers). Mean urinary cadmium 0.81 µg/g creatinine (males) and 0.65 µg/g creatinine (females). The prevalence of abnormal pHC (human complex-forming glycoprotein, also known as α1-microglobulin) values was estimated to increase by 10 percent at a urinary cadmium level of 1 µg/g creatinine. The European Chemicals Bureau (2007) recalculation against the raw data, accounting for age differences between the reference and study populations, gave the urinary cadmium level associated with a 10 percent increased probability of abnormal pHC values (20 percent total probability) as 2.62 µg/g creatinine for the total population; in the nonworker subgroup a urinary cadmium level of 0.5 µg/g creatinine was associated with a 13 percent probability (doubling of reference-population probability) of abnormal pHC values (TAB B, p. 24).
  • Suwazono et al. (2006) — Swedish women, key study for chronic ADI: 820 Swedish women with no particular environmental or occupational cadmium exposure. Using a benchmark-dose approach and a cutoff based on the 95th percentile of urinary protein excretion estimated for a person with no cadmium exposure, the critical urinary cadmium concentration was estimated at 0.6–1 µg cadmium/g creatinine for a 5 percent excess risk based on excretion of NAG (N-acetyl-β-D-glucosaminidase) and pHC. The lower confidence limit of the BMD (the BMDL) was 0.5 µg cadmium/g creatinine (TAB B, p. 25; Staff Report, p. 4).
  • Cadmium bone-effect critical concentrations (Suwazono et al. 2010 reanalysis of Swedish women): critical urinary cadmium concentration of 1.8–3.7 µg/g creatinine for a 5 percent excess risk of low bone mineral density; BMDL of 1.0–2.1 µg/g creatinine (TAB B, p. 27).
  • U.S. women NHANES analysis (Gallagher et al. 2008, NHANES III 1988–1994 and 1999–2004): women ≥ 50 years of age with urinary cadmium between 0.50 and 1.00 µg/g creatinine had a 43 percent greater risk for osteoporosis relative to those with levels less than or equal to 0.50 µg/g creatinine. Authors estimated about 21 percent of osteoporosis prevalence among women at least 50 years of age may be attributable to cadmium (TAB B, p. 27).
  • Carcinogenicity: cadmium and cadmium compounds are listed as “known to be human carcinogens” in the U.S. National Toxicology Program Report on Carcinogens (NTP 2005), based on inhalation-exposure studies in workers. Cadmium is not classified as an oral carcinogen from oral-exposure studies (insufficient evidence in humans and experimental animals) (TAB B, p. 29).

Behavioural and ingestion-pathway data underlying the FHSA assessment (Staff Report, p. 8)

  • Emergency-room-treated injuries from ingestion of consumer products by children, 2000–2005 (CPSC analysis of NEISS): about 302,587 estimated injuries, nearly 80 percent in children under age 7 years. The most commonly swallowed objects were coins (≈ half of ingestions), jewelry, toys not elsewhere classified, and nails, screws, tacks, or bolts (CPSC 2006b, cited in Staff Report).
  • GI transit time for ingested foreign bodies in children (Macgregor and Ferguson 1998): 100 children ages 9 months to 13 years swallowed various foreign bodies including coins, ball bearings, pins, marbles, screws, buttons, a light bulb, a novelty nail file, and a clothespin. Total transit time 1 to 46 days; peak time of passage 2 days; median time 6 days. Mean transit time increased with age — greater than 15 days for 13-year-olds; typically 5 days for 4-to-10-year-olds (Staff Report, p. 8–9). This is the data underlying the 24-hour acid-extraction test duration choice.

Methods (brief)

The 109-page PDF contains (i) a 2-page transmittal letter from Colin Church (CPSC Voluntary Standards Coordinator) to Brent Cleaveland (Chairman, ASTM F-15.24 Subcommittee on Children’s Jewelry, c/o Fashion Jewelry and Accessories Trade Association), dated October 19, 2010; (ii) the Staff Report memorandum on Children’s Cadmium-Containing Metal Jewelry, dated October 14, 2010, from Kris M. Hatlelid (Toxicologist, CPSC Directorate for Health Sciences) to Mary Ann Danello (Associate Executive Director, Directorate for Health Sciences) through Lori E. Saltzman (Director, Division of Health Sciences) — 13 pages including references; (iii) TAB A: Staff Responses to Peer Review Comments, dated October 14, 2010, from Kris M. Hatlelid (5 pages), documenting CPSC staff responses to comments received from three external scientific peer reviewers in June–July 2010 on the draft Staff Report; (iv) TAB B: Toxicity Review of Cadmium, dated October 14, 2010, from Dominique J. Williams and Kris M. Hatlelid (90 pages including references and supporting tables), providing the underlying CPSC Health Sciences staff assessment of cadmium toxicity used to support the Staff Report’s exposure derivations.

No new analytical chemistry or product-content measurements are reported. The Staff Report’s derivation methodology consists of: (a) selection of Suwazono et al. (2006) as the key chronic-toxicity study from a body of European and Japanese kidney-epidemiology dose-response analyses (other dose-response studies considered in TAB B include Järup et al. 2000; Jin et al. 2004; Kobayashi et al. 2006; Shimizu et al. 2006; Uno et al. 2005); (b) PK-conversion of the Suwazono BMDL of 0.5 µg cadmium/g creatinine to a cadmium intake level of 0.33 µg/kg/day using the ATSDR 2008 European-population analysis; (c) application of a 3-fold uncertainty factor (reduced from default 10) to derive the chronic ADI of 0.1 µg/kg/day; (d) selection of Borzelleca et al. (1989) as the key acute-toxicity animal study and application of a 100-fold composite uncertainty factor (10× animal-to-human × 10× sensitive subpopulations) to the NOAEL of 1.1 mg/kg/day to derive the acute ADI of 11 µg/kg/day; (e) translation of the ADIs to per-day exposure values for a 2-to-6-year-old (18.2 kg body weight); (f) translation of the per-day exposure values to laboratory extraction-test thresholds (6-hour saline extraction → 18 µg total cadmium for mouthable items based on CPSC 2001 mouthing-observation data; 24-hour acid extraction → 200 µg total cadmium for swallowable items based on Macgregor and Ferguson 1998 GI transit-time data). The acute ADI of 11 µg/kg/day is the staff’s response to peer-review comments that the draft document’s swallowing-scenario approach was inadequate; the revised analysis uses published acute studies in experimental animals rather than the original 1973 Nordberg case-study extrapolation, which staff judged inadequately documented for derivation of a quantitative exposure limit.

The peer-review comments addressed in TAB A include (verbatim or in summary): the form of cadmium and dose route in toxicology studies and the form expected from children’s products; the renal cortex concentration threshold concept and database; whether bone effects should be considered in derivation of the ADI; the relationship between long-term and intermediate-term LOAELs and NOAELs; reconsideration of the default uncertainty factor; modelling of short-term exposure based on effects on kidney cadmium concentration; the appropriateness of the swallowing-scenario approach; the need for and form of an acute exposure limit; how acute and chronic mechanisms of action might differ; recent data on increased urinary cadmium excretion in children ages 6–11 years and in females; and whether CPSC was deriving a higher chronic ADI than the ATSDR chronic MRL or USEPA RfD (staff response: the revised CPSC chronic ADI of 0.1 µg/kg/day is the same as the ATSDR’s draft chronic MRL).

Implications

  • HMTc audit implications. This document is the U.S. federal-agency staff position underlying CPSC enforcement of cadmium content in children’s metal jewelry under the Federal Hazardous Substances Act (FHSA). For any HMTc certification work that addresses children’s jewelry or jewelry-adjacent metal accessories sold for children, the laboratory test thresholds derived in this Staff Report (18 µg total cadmium in 6-hour saline extraction for mouthable items; 200 µg total cadmium in 24-hour dilute-acid extraction for swallowable items) are the U.S. federal-agency-defined exposure-evaluation reference points. Both thresholds are the CPSC staff’s per-FHSA test method that would, if exceeded, indicate the product may meet the FHSA’s “hazardous substance” criteria. The underlying chronic ADI of 0.1 µg/kg/day (cadmium) is identical to the ATSDR (2008) draft chronic-duration oral MRL and is at the more conservative end of the international convention space (compared with the U.S. EPA RfD of 1.0 µg/kg/day for food and 0.5 µg/kg/day for water, and the WHO/JECFA PTMI equivalent to about 0.8 µg/kg/day). HMTc thresholds set in alignment with the 0.1 µg/kg/day chronic ADI should be tagged regulatory-alignment; thresholds set below should be tagged precautionary per Part 19 conventions.
  • Cross-reference to compliance baselines. The CPSC test thresholds in this Staff Report are the test-method translation of the ADI; they are not content-restriction limits in the sense of Washington State CSPA’s 40 ppm cadmium content limit on children’s products. The two regimes operate on different axes — FHSA tests extraction/migration in mouthing or swallowing scenarios, CSPA restricts substrate content. Compliance findings in sekerak2016-wa-childrens-jewelry (cadmium up to 98.4 % by mass in necklace pendants sold with children’s apparel) would, on per-extraction laboratory testing under the CPSC method, likely exceed the 18 µg saline or 200 µg acid extraction thresholds, pending per-item extraction testing under the CPSC 6-hour saline and 24-hour dilute-acid protocols; the FHSA and CSPA regimes are complementary, with FHSA addressing the exposure end and CSPA addressing the content end of the same hazard. The Sekerak 2016 findings are not extraction-tested in that source and are not extraction-tested in this CPSC document; the inference is a category-level cross-reference, not a CPSC-published finding.
  • App. Not directly relevant to ingredient contamination_profile data because no food-matrix occurrence values are reported. Relevant to a future children’s-product screening surface that explains the CPSC’s per-item extraction-test framework (mouthing vs swallowing scenarios) and the underlying 0.1 µg/kg/day chronic and 11 µg/kg/day acute ADIs.
  • Courses. Worked example for the regulatory-derivation module of how an agency uses a benchmark-dose epidemiological study (Suwazono et al. 2006) plus PK conversion (ATSDR 2008) plus a reduced uncertainty factor (3 rather than 10) to derive a chronic ADI for an oral exposure to a metal contaminant, and then how that ADI is translated to per-item laboratory extraction-test thresholds via mouthing-time and GI-transit-time behavioural data. The acute ADI derivation from an animal NOAEL using a 100-fold composite uncertainty factor is a complementary worked example. The peer-review-response document (TAB A) is a useful primary-source example of agency-staff responsiveness to external scientific review of a draft regulatory-derivation document.
  • Microbiome. Not applicable. No biological matrix and no exposure-pathway measurements relevant to gut microbiome interaction. The toxicokinetics discussion in TAB B is limited to absorption (≈ 1–10 % oral), tissue distribution (kidney and liver predominant), metabolism (metallothionein binding), and excretion (≈ 0.007 % feces, 0.009 % urine per day of body burden).

Wiki pages this source may touch

Verification notes

  • Source identification. U.S. Consumer Product Safety Commission. (2010). Children’s Cadmium-Containing Metal Jewelry — Staff Report. Bethesda, MD: CPSC Directorate for Health Sciences. 109 pp. Transmitted October 19, 2010 by Colin Church (Voluntary Standards Coordinator, CPSC) to Brent Cleaveland (Chairman, ASTM F-15.24 Subcommittee on Children’s Jewelry, c/o Fashion Jewelry and Accessories Trade Association). Three constituent staff memoranda dated October 14, 2010: Hatlelid (Staff Report), Hatlelid (Staff Responses to Peer Review Comments, TAB A), Williams and Hatlelid (Toxicity Review of Cadmium, TAB B).
  • Author attribution. Three CPSC staff authors are listed in frontmatter: Kristina M. Hatlelid, Ph.D., M.P.H. (sole author of the Staff Report and of TAB A; co-author of TAB B), Dominique J. Williams (co-author of TAB B Toxicity Review), and Colin Church (Voluntary Standards Coordinator, signatory of the October 19, 2010 transmittal letter). Hatlelid is listed first as the primary author of the Staff Report’s regulatory-derivation work product. The full first name “Kristina” appears in the memorandum FROM lines on p. 1 of the Staff Report, p. 15 of TAB A, p. 20 of TAB B, and the cc list on p. 2 of the cover letter; the cite-key uses cpsc2010 rather than hatlelid2010 to reflect that the document is institutionally authored as a CPSC staff document spanning three memoranda, consistent with the corpus convention used for other CPSC institutional documents (cpsc1997-pvc-children-products, cpsc2009-cpsia-101-procedures-npr, cpsc2009-cpsia-101b-inaccessibility-rule, cpsc2012-cpsia-101b-functional-purpose-exception). The existing hatlelid2009-cpsc-cpsia-lead-childrens-products page in the corpus uses the abbreviated first-name form “Kris Hatlelid”; for this 2010 document the full agency-of-record first name “Kristina” is preserved as it appears in the source. (Audit subagent 2026-06-01 flagged the original draft’s use of “Kris M. Hatlelid” as inconsistent with the PDF’s “Kristina M. Hatlelid”; verified against Staff Report p. 1, TAB A p. 15, TAB B p. 20, and cover letter p. 2 — corrected.)
  • DOI. No DOI assigned; U.S. federal agency staff reports are not normally DOI-registered. doi: null with no_doi_assigned: true. The access_url field is populated with the CPSC root because the original public posting URL (if any) for the 2010 Staff Report is not present on the document itself; the document is in the public domain as a U.S. government work and is widely available through CPSC and FOIA archives.
  • License. public-reference-only: U.S. federal-agency staff document, public-domain as a U.S. government work. Matches the corpus convention used for hatlelid2009-cpsc-cpsia-lead-childrens-products. Distribution and citation are unrestricted.
  • Tier rationale. A-tier per Part 13: U.S. federal-agency staff guidance/report citing the primary peer-reviewed cadmium-toxicology literature (Suwazono et al. 2006; Borzelleca et al. 1989; ATSDR 2008; and ~50 other peer-reviewed primary sources) and deriving the FHSA-applicable test thresholds. The standard CPSC staff caveat (“These comments are those of the CPSC staff, have not been reviewed or approved by, and may not necessarily reflect the views of, the Commission”) slightly qualifies the institutional weight of the interpretive framing, but the underlying ADI derivation and the supporting toxicology review are agency-of-record and A-tier. Matches existing handling of hatlelid2009-cpsc-cpsia-lead-childrens-products, cpsc2009-cpsia-101-procedures-npr, cpsc2009-cpsia-101b-inaccessibility-rule, and cpsc2012-cpsia-101b-functional-purpose-exception already in the corpus.
  • Source-type rationale. source_type: gov-guidance: the document is a U.S. federal-agency staff guidance document deriving an FHSA-applicable test-method framework, not a primary research publication and not a finalised rulemaking. Matches the existing handling of hatlelid2009-cpsc-cpsia-lead-childrens-products (which is source_type: gov-guidance).
  • Frontmatter metals: [Cd]. The document is specifically about cadmium in children’s metal jewelry; cadmium is the only metal analyte for which exposure limits and test thresholds are derived. Per CLAUDE.md Part 14, cadmium is Cd. No speciation question arises — the document refers throughout to total cadmium (as a metal contaminant in jewelry alloys) and to oral cadmium exposure without distinguishing among inorganic cadmium species. Lead is referenced once in passing (in the context of CPSC’s earlier lead-in-jewelry briefing package, CPSC 2006a) but is not the subject of any derivation or threshold here; not included in metals:.
  • Frontmatter ingredients: []. Correct — no food ingredients involved. This is a consumer-product regulatory-derivation document for children’s metal jewelry.
  • Frontmatter matrices: []. Correct — no food or biological matrices. The “matrices” relevant to the document’s test thresholds are saline solution and dilute hydrochloric acid solution as laboratory extraction media, which are not in the food/biomonitoring matrices controlled vocabulary the routing layer routes on. The TAB B Toxicity Review references biomonitoring matrices (blood, urine, kidney tissue, liver tissue) in the context of NHANES and population biomonitoring studies, but those are descriptive of the underlying toxicology evidence base rather than measurements made in this study.
  • Frontmatter products: ["[[products/childrens-jewelry]]"]. Single broad slug, the children’s-jewelry umbrella that already exists as a provisional scaffold in the taxonomy (created 2026-05-31 during ingest of nelson2023-wa-childrens-jewelry-followup). The document scope is “children’s cadmium-containing metal jewelry” without further sub-form differentiation; routing to the umbrella slug is the correct broad-scope choice per Part 5b. Sub-form slugs (necklaces, charms, pendants, bracelets, earrings, rings) are not separately analysed by the document.
  • Frontmatter jurisdictions: [US]. Correct — CPSC, FHSA, and the underlying U.S. federal regulatory framework. The Staff Report references international cadmium toxicology literature (European and Japanese kidney-epidemiology studies; WHO/JECFA PTMI; European EN 71-3 and Council Directive 2009/48/EC toy-safety limits) but the document’s derivation work product is for U.S. FHSA-applicable test thresholds. Convention is country-level codes.
  • Brand-firewall (Part 12, strict reading locked 2026-05-17). The document names no brands. The cover letter is addressed to Brent Cleaveland in his capacity as Chairman of the ASTM F-15.24 Subcommittee, c/o the Fashion Jewelry and Accessories Trade Association (a trade association, not a brand). No brand-firewall concern arises.
  • Scientific-method vendor/material names (Part 12 Exception 2). The Staff Report names CPSC’s standard laboratory protocols (6-hour saline extraction, 24-hour dilute hydrochloric acid extraction) and references the methodological foundation (CPSC 2001 mouthing observation study; CPSC 2006a, 2006b lead-in-jewelry briefing-package methodology). These are scientific-method identifications, not brand attributions of contamination values, and are preserved per the locked Exception 2 reading. TAB B’s Toxicity Review references specific peer-reviewed studies (Suwazono et al. 2006; Borzelleca et al. 1989; Jurup et al. 2000; etc.) which are scientific citations, not commercial brand attributions.
  • Wiki/HMTc firewall (Part 2). The Implications section reports the agency’s derived thresholds as expressed in the source. It does not propose HMTc threshold values, does not soften or strengthen the reported values, and frames the relationship to other US and international cadmium exposure limits as descriptive cross-reference rather than as synthesis or HMTc-alignment work. The HMTc audit-implications bullet describes what the staff-derived test thresholds contribute to threshold work (an agency-of-record reference point for an FHSA-grounded test methodology) without proposing an HMTc threshold, on the allowed side of the Part 2 boundary per audit-prompt.md. The Cross-reference to compliance baselines bullet relates this FHSA migration-test framework to the separate CSPA content-restriction regime documented elsewhere in the corpus (Sekerak 2016), framed as a descriptive comparison rather than as synthesis.
  • Speciation flag. Not applicable for cadmium — the document refers throughout to total cadmium without speciation. Methylcadmium, organocadmium, or specific cadmium-salt distinctions are not made in the derivation or in the threshold framework. The acute-toxicity study (Borzelleca et al. 1989) uses cadmium chloride as the test substance, and the Staff Report acknowledges that forms of cadmium in consumer products vary from cadmium metal in alloys (including solder and electroplating materials) to cadmium salts and other compounds (Staff Report, p. 3).
  • Regulation cross-references. The document references several regulatory artefacts already in the wiki: ATSDR cadmium MRLs ([[regulations/atsdr-cadmium-mrls]]), the U.S. EPA cadmium RfD ([[regulations/epa-iris-cadmium-rfd]]), and the WHO/JECFA cadmium PTMI ([[regulations/jecfa-cadmium-ptmi]]), all of which have dedicated regulations pages. The CPSC’s own FHSA framework, the 16 CFR §1500.3(c)(2)(i) acute-exposure definition, and the European EN 71-3 (1994) and Council Directive 2009/48/EC toy-safety limits do not currently have dedicated wiki/regulations/ pages; not created speculatively from this single source (regulations created on first encounter only if they are hard agency identifiers with established CPSC/EU rulemaking lineage — that is true here, but per the v2 skill stop conditions, “new regulation slug needed” is a Karen-attention case rather than an autonomous-creation case, so deferred to a separate workflow).
  • Folder context vs paper scope. The PDF lives under _extracted_infantdurable_04_Fasteners_Snaps_Zippers/04_Fasteners_Snaps_Zippers/ in the Kimi corruption-issue raw tree, but the document is not a fastener, snap, or zipper study — it is a CPSC staff report on cadmium in children’s metal jewelry. The folder naming reflects the Kimi-agent’s batch-organisation scheme during the May 21 corruption-recovery extraction, not the paper’s actual content. The product slug is childrens-jewelry, not a fastener/snap/zipper slug. Mirrors the same folder-vs-scope note in sekerak2016-wa-childrens-jewelry.
  • Document-vs-cover-letter scope. The October 19, 2010 cover letter from Colin Church to Brent Cleaveland refers to “Tabs A and B” containing the results of testing jewelry and metal alloy samples; the cover letter is a 2-page document. The 109-page PDF that follows contains the full Staff Report plus a separate TAB A (Staff Responses to Peer Review Comments) and TAB B (Toxicity Review of Cadmium). The jewelry/metal-alloy testing results referenced in the cover letter as “Tabs A and B” are not in the body of this PDF — they appear to refer to the separate CPSC staff report “Staff Report on Toy Standard Test Methods with Data from Testing Metal Jewelry and Other Materials,” dated August 2010, which was an enclosed companion document and is not part of this file. The Key numbers section above accordingly contains only the derivation-and-threshold material from the Staff Report and the dose-response material from TAB B, not jewelry-sample concentration measurements.
  • Number transcription notes.
    • 1.8 µg/day chronic exposure value: Staff Report p. 8 reports the computation as “the maximum allowable chronic exposure for young children is about 1.8 µg/day” with the underlying arithmetic 0.1 µg/kg/day × 18.2 kg = 1.82 µg/day rounded.
    • 200 µg/day acute exposure value: Staff Report p. 8 reports the computation as “the maximum allowable acute exposure for a young child is about 200 µg/day” with the underlying arithmetic 11 µg/kg/day × 18.2 kg = 200.2 µg/day rounded.
    • 18 µg saline extraction threshold: Staff Report p. 9 derives this as (1.8 µg/day) / (37 min/day) × (6 hours × 60 min/hour) = 18 µg in Eq. 1. The 37 min/day mouthing-time figure is from CPSC (2001) for ages 24–36 months for all objects excluding pacifiers.
    • 200 µg acid extraction threshold: Staff Report p. 10 states that “the acute ADI would be exceeded if the result of the acid extraction of the item exceeds 200 micrograms total cadmium extracted during the 24-hour acid extraction” — the acute-ADI value (200 µg/day) is taken as the total extraction over the 24-hour test rather than as a per-day rate, because the swallowed-item exposure occurs entirely within the short time the item remains in the GI tract.
    • Suwazono BMDL 0.5 µg/g creatinine: Staff Report p. 4 and TAB B p. 25 both report this as the lower confidence limit of the BMD for 5 percent excess risk of kidney protein excretion in 820 Swedish women.
    • Chronic-ADI uncertainty factor of 3 (rather than default 10): Staff Report p. 5 and TAB A p. 16 both explain this as a reduced uncertainty factor reflecting the strength of the supporting human-population evidence.
    • Acute-ADI uncertainty factor of 100: Staff Report p. 7 explains this as a 10× factor for use of animal data instead of human data plus a 10× factor for sensitive individuals in the human population, applied to the Borzelleca et al. (1989) NOAEL of 1.1 mg/kg/day.
    • 11 µg/kg/day acute ADI = 1.1 mg/kg/day ÷ 100 (uncertainty-factor product). The mg → µg conversion is consistent with the Staff Report’s footnote 4 (p. 3): “1 mg = 1,000 µg,” so 1.1 mg/kg/day ÷ 100 = 0.011 mg/kg/day = 11 µg/kg/day.
    • Järup et al. (2000) — name correctly spelled with ä-umlaut per the Staff Report references list (p. 12: “Järup L, Hellstrom L, Alfven T…”). (Audit subagent 2026-06-01 flagged the original draft’s “Jurup” spelling as a transcription error; verified against the Staff Report references — corrected to “Järup”.)
    • Borzelleca et al. (1989) rat strain — the Staff Report’s narrative on p. 5–6 describing the 10-day drinking-water arm states “groups of male and female rats” without specifying strain. TAB B p. 23 attributes the companion single-dose gavage arm of Borzelleca et al. (1989) to Sprague-Dawley rats. The wiki page’s Key numbers entry for the drinking-water arm therefore now records “male and female rats (strain not specified for the drinking-water arm)” with the Sprague-Dawley attribution noted as TAB B p. 23 evidence for the gavage arm, rather than implicitly extending the gavage-arm strain to the drinking-water arm. (Audit subagent 2026-06-01 flagged the original draft’s blanket “Sprague-Dawley rats” attribution for the drinking-water arm as an over-attribution; verified against Staff Report p. 5–6 and TAB B p. 23 — corrected to the source’s exact wording.)
    • TAB B internal-contradiction on cadmium excretion fractions — TAB B p. 22 (Toxicokinetics section): “Excretion is very slow, with approximately 0.007 and 0.009 percent of the body burden being excreted in the urine and feces, respectively, per day (ATSDR, 2008)” — that is, 0.007 % = urine, 0.009 % = feces. TAB B p. 23 (Elimination section): “From the model, these authors estimated that daily excretion in feces and urine is approximately 0.007 and 0.009 percent of body burden, respectively” — that is, 0.007 % = feces, 0.009 % = urine. The wiki page’s Key numbers entry adopts the p. 23 Elimination-section attribution because the Elimination section is the TAB B section that derives the toxicokinetic-model parameters and presents the per-day fractions as the model output; the p. 22 Toxicokinetics opening summary appears to be a transposition of the order of “urine and feces” labels relative to “0.007 and 0.009 percent” values rather than an independent model derivation. The contradiction is noted in the Key numbers entry itself so future readers can compare both source pages. (Audit subagent 2026-06-01 flagged the internal-source contradiction; verified against TAB B p. 22 and p. 23 — wiki adopts p. 23 with explicit contradiction note.)
  • n vs sample-population. No analytical n applies. sample_n: null is correct. The sample_population field describes the document’s scope (derivation of exposure thresholds rather than measurement of jewelry samples) and explicitly notes the absence of the jewelry/metal-alloy test data referenced in the cover letter.
  • Near-duplicates. None identified in the current corpus. The companion CPSC document referenced in the cover letter (“Staff Report on Toy Standard Test Methods with Data from Testing Metal Jewelry and Other Materials,” dated August 2010) is not in the corpus and would be a complementary source if added later; the corpus’s existing CPSC staff documents (hatlelid2009-cpsc-cpsia-lead-childrens-products, cpsc2009-cpsia-101-procedures-npr, cpsc2009-cpsia-101b-inaccessibility-rule, cpsc2012-cpsia-101b-functional-purpose-exception, johnson2012-cpsc-astm-f963-status, cpsc1997-pvc-children-products) cover lead in children’s products and related FHSA/CPSIA framework rather than cadmium in metal jewelry specifically, so no near-duplicates are claimed.
  • Raw integrity. raw_sha256 = eb72509f53a5cf8c9bfde121a6b0b04deb90c38fb74fffcbf1221a40c05896f0 verified by shasum -a 256 against the file at raw_path.
  • Funding and conflicts. Not applicable: U.S. federal-agency staff communication; no funding disclosure or conflict-of-interest statement applies to a CPSC staff report. The staff caveat (“These comments are those of the CPSC staff and have not been reviewed or approved by, and may not necessarily reflect the views of, the Commission”), which appears on the cover letter, on the Staff Report, on TAB A, and on TAB B, is the relevant institutional disclaimer.

Page history

The five most recent substantive edits to this page. The full version history lives in git; when DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.

CommitDateDescription
c1aef382026-06-02audit-queue: hamid2021-bacterial-plant-biostimulants-review → audited-promote